168 related articles for article (PubMed ID: 17932671)
1. Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma.
Yang SH; Kuo SH
Ann Hematol; 2008 Apr; 87(4):325-7. PubMed ID: 17932671
[No Abstract] [Full Text] [Related]
2. Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab.
Hernández JA; Diloy R; Salat D; del Río N; Martínez X; Castellví JM
Haematologica; 2003 Jun; 88(6):ECR22. PubMed ID: 12801855
[No Abstract] [Full Text] [Related]
3. Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma.
Perceau G; Diris N; Estines O; Derancourt C; Lévy S; Bernard P
Br J Dermatol; 2006 Nov; 155(5):1053-6. PubMed ID: 17034541
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B reactivation in a patient receiving radiolabeled rituximab.
Soong YL; Lee KM; Lui HF; Chow WC; Tao M; Li Er Loong S
Ann Hematol; 2005 Jan; 84(1):61-2. PubMed ID: 15449029
[No Abstract] [Full Text] [Related]
5. Hepatitis B reactivation induced by Rituximab maintenance therapy for lymphoma.
Cho CH; Hwang WL; Cheng SB; Lee TY; Teng CL
Ann Hematol; 2011 Jan; 90(1):111-2. PubMed ID: 20407894
[No Abstract] [Full Text] [Related]
6. [Reactivation of hepatitis B virus in patients with hematological neoplasms].
Takkenberg RB; Zaaijer HL; ten Cate DF; Biemond BJ; Jansen PL; Reesink HW
Ned Tijdschr Geneeskd; 2009 May; 153(19):926-31. PubMed ID: 19489299
[No Abstract] [Full Text] [Related]
7. Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab.
Dervite I; Hober D; Morel P
N Engl J Med; 2001 Jan; 344(1):68-9. PubMed ID: 11187122
[No Abstract] [Full Text] [Related]
8. The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.
He YF; Li YH; Wang FH; Jiang WQ; Xu RH; Sun XF; Xia ZJ; Huang HQ; Lin TY; Zhang L; Bao SP; He YJ; Guan ZZ
Ann Hematol; 2008 Jun; 87(6):481-5. PubMed ID: 18299831
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
[TBL] [Abstract][Full Text] [Related]
10. A case of non-Hodgkin's lymphoma-associated pemphigus foliaceus and use of rituximab for treatment.
Prodanovic EM; Korman NJ
J Dermatolog Treat; 2008; 19(6):1-3. PubMed ID: 18720187
[TBL] [Abstract][Full Text] [Related]
11. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of hepatitis B virus with rituximab.
Tsutsumi Y; Kanamori H; Mori A; Tanaka J; Asaka M; Imamura M; Masauzi N
Expert Opin Drug Saf; 2005 May; 4(3):599-608. PubMed ID: 15934864
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus reactivation in a patient with resolved hepatitis B virus infection receiving maintenance rituximab for malignant B-cell lymphoma.
Koo YX; Tan DS; Tan IB; Tao M; Lim ST
Ann Intern Med; 2009 May; 150(9):655-6. PubMed ID: 19414854
[No Abstract] [Full Text] [Related]
14. Precursor B-lymphoblastic transformation of grade I follicle center lymphoma following rituximab therapy.
Follows GA; McVerry A; Owen RG
Am J Clin Pathol; 2000 Dec; 114(6):982-3. PubMed ID: 11338486
[No Abstract] [Full Text] [Related]
15. Hepatitis B re-activation with rituximab therapy: treat the patient not the disease.
Zachou K; Dalekos GN
Liver Int; 2011 Mar; 31(3):277-9. PubMed ID: 21281426
[No Abstract] [Full Text] [Related]
16. Rituximab and statins.
Carver JR; Johnson T; Schuster SJ
J Clin Oncol; 2010 Oct; 28(30):e611; author reply e612. PubMed ID: 20805449
[No Abstract] [Full Text] [Related]
17. An imaging-based rapid evaluation method for complement-dependent cytotoxicity discriminated clinical response to rituximab-containing chemotherapy.
Mishima Y; Sugimura N; Matsumoto-Mishima Y; Terui Y; Takeuchi K; Asai S; Ennishi D; Asai H; Yokoyama M; Kojima K; Hatake K
Clin Cancer Res; 2009 May; 15(10):3624-32. PubMed ID: 19417028
[TBL] [Abstract][Full Text] [Related]
18. Rituximab-associated infections.
Gea-Banacloche JC
Semin Hematol; 2010 Apr; 47(2):187-98. PubMed ID: 20350666
[TBL] [Abstract][Full Text] [Related]
19. Factors predictive for response of follicular and mantle-cell lymphoma to rituximab.
Pfreundschuh M
Nat Clin Pract Oncol; 2006 Apr; 3(4):184-5. PubMed ID: 16596141
[No Abstract] [Full Text] [Related]
20. Current status of rituximab maintenance therapy.
Vose JM
Clin Adv Hematol Oncol; 2007 Dec; 5(12):968-9,1006. PubMed ID: 18277958
[No Abstract] [Full Text] [Related]
[Next] [New Search]